Tag: Patient Safety

ERAS program for total joints reduces length of stay

Editor's Note Use of an Enhanced Recovery after Surgery (ERAS) program in total hip and total knee patients reduced length of stay by 1 day in this study. Short term complications and readmission rates were similar for patients in the ERAS program and those managed in a traditional perioperative care…

Read More

By: Judy Mathias
March 28, 2016
Share

Surgeons to use HCV infected kidneys for transplant

Editor's Note Surgeons at the University of Pennsylvania and Johns Hopkins University hospitals will transplant kidneys from donors with hepatitis C virus (HCV) as part of a clinical trial this spring, STAT news reports. The recipients will be given a 12-week course of antiviral therapy after the transplant in hopes…

Read More

By: Judy Mathias
March 24, 2016
Share

Study: Increase in operative variability among surgical residents since 80-hour workweek

Editor's Note In this study of surgical residents after implementation of the 80-hour workweek in 2003, researchers found a significant increase in operative variability, including an increase in the variability of total major cases between the resident completing the most and fewest cases per class. This may suggest a growing disparity…

Read More

By: Judy Mathias
March 24, 2016
Share

FDA: Hospira recalls one lot of Sodium Bicarbonate Injection

Editor's Note The Food and Drug Administration (FDA) on March 21 announced the recall by Hospira, Inc (Lake Forest, Illinois) of one lot of 8.4% Sodium Bicarbonate Injection, USP (NDC: 0409-6625-02, Lot 56-148-EV, Expiry August 1, 2017). The recall was initiated because of the presence of a particulate in a single-dose…

Read More

By: Judy Mathias
March 24, 2016
Share

Peripheral nerve blocks linked to better total joint outcomes

Editor's Note Peripheral nerve blocks were associated with fewer complications and lower costs in total hip and knee patients in this study, which was presented March 23 at the annual meeting of the American Society of Regional Anesthesia and Pain Medicine. In this analysis of more than 1 million patients…

Read More

By: Judy Mathias
March 24, 2016
Share

AHRQ’s Patient Safety Chartbook shows 17% decline in HACs

Editor's Note Patient safety in hospitals improved from 2010 to 2014 as the overall rate of hospital-acquired conditions (HACS) declined 17%, according to the new National Healthcare Quality and Disparities Report Patients Safety Chartbook from the Agency for Healthcare Research and Quality (AHRQ). The overall HAC rate declined from 145/1,000…

Read More

By: Judy Mathias
March 23, 2016
Share

FDA proposes ban on most powdered gloves

Editor's Note The Food and Drug Administration (FDA) on March 21 announced a proposal to ban most powdered gloves in the US. The proposed ban applies to powdered surgeons' gloves, powdered patient examination gloves, and absorbable powder for lubricating surgeons' gloves. Powdered gloves pose an unreasonable and substantial risk of…

Read More

By: Judy Mathias
March 22, 2016
Share

Patient factors strongly predict 30-day readmissions

Editor's Note The patient’s clinical condition responsible for admission, age, comorbidities, and socioeconomic factors such as race, income, and payer status were strong predictors of readmission within 30 days in this study. The analysis included some 15 million patients at 611 hospitals from Premier healthcare alliance over a 2-year period.…

Read More

By: Judy Mathias
March 22, 2016
Share

Joint Commission approves new, revised NPSGs for CAUTIs

Editor's Note The Joint Commission on March 21 approved a new National Patient Safety Goal (NPSG) on catheter-associated urinary tract infections (CAUTIs) for accredited nursing care centers. Also approved were revisions for the existing CAUTI NPSG for accredited hospitals and critical access hospitals, which were made to bring the NPSG…

Read More

By: Judy Mathias
March 22, 2016
Share

FDA: Class I recall of GlideScope Titanium Single-Use Video Laryngoscope

Editor's Note The Food and Drug Administration (FDA) on March 18 announced the Class I recall of the GlideScope Titanium Single-Use Video Laryngoscope by Verathon (Bothell, Washington). Class I is the most serious. The recall was initiated because of a potential disruption in the video feed from the laryngoscope blade…

Read More

By: Judy Mathias
March 21, 2016
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat